Cancer Nanotechnology

Nanotechnology offers exceptional specificity, sensitivity, and the ability to perform multiplexed measurements, making it a promising tool for the detection of extracellular cancer cells, cancer biomarkers, and in vivo imaging. While it has not yet been widely adopted for clinical cancer diagnosis, nanotechnology is already utilized in various diagnostic platforms—for example, gold nanoparticles are used in commercial home pregnancy tests. In cancer diagnostics, nanoparticles are being explored for their ability to capture key cancer biomarkers, including circulating tumor DNA (ctDNA), circulating tumor cells (CTCs), exosomes, and cancer-associated proteins.

    Related Conference of Cancer Nanotechnology

    July 28-29, 2025

    45th Euro Congress on Cancer Science & Therapy

    Paris, France
    October 20-21, 2025

    21st International Conference on Cancer Research

    Barcelona, Spain
    October 22-23, 2025

    35th Experts Meet On Cancer Research & Therapy

    Paris, France
    October 24-25, 2025

    25th World Congress on Cancer and Diagnostics

    Zurich, Switzerland
    November 20-21, 2025

    26th World Congress on Cancer Summit

    Amsterdam, Netherlands
    November 24-25, 2025

    43rd World Cancer Conference

    Barcelona, Spain
    December 08-09, 2025

    13th Euro Breast Cancer and Therapeutics

    Aix-en-Provence, France
    February 19-20, 2026

    7th Cancer Diagnostics & Treatment Conference

    Miami, USA
    February 19-20, 2026

    8th International Conference on Women Oncology

    Miami, USA
    March 23-24, 2026

    16th World Congress on Breast Cancer Research & Therapies

    Aix-en-Provence, France

    Cancer Nanotechnology Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in